Prosight Management’s Cano Health, Inc. CANO Stock Holding History

Prosight Management’s Portfolio CANO Stock Details CANO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-232	Closed	-$281K	–	56
2021 Q2	$281K	Buy	+232	New	+$313K	0.18%	45

Other funds holding CANO

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Third Point New York $4.68B AUM 37.3% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Prosight Management's CANO Position: Q3 2021 in Review

Prosight Management sold out of Cano Health, Inc. (CANO) in Q3 2021, closing a stake of 232 shares — an estimated $281K sold.

Prosight Management first reported a position in CANO in Q2 2021 and held it in 1 quarter. The position peaked at $281K in Q2 2021. 110 funds tracked by Wall St. Rank hold CANO as of Q3 2021.

Prosight Management reported no remaining Cano Health, Inc. position as of Q3 2021 after selling out during the quarter.
Prosight Management sold 232 Cano Health, Inc. shares in Q3 2021, an estimated $281K.
Prosight Management first reported a position in Cano Health, Inc. in Q2 2021 and held it in 1 quarter.
Prosight Management's Cano Health, Inc. position peaked at $281K in Q2 2021.
110 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q3 2021.

Based on Prosight Management's 13F filing for Q3 2021, filed 12 Nov 2021.